• Skip to primary navigation
  • Skip to content
  • Skip to footer navigation
Aucta Pharma

Aucta Pharma

  • About Aucta
    • Aucta Introduction
    • Aucta Values
    • Aucta Vision
    • Management Team
  • Strategy
    • Strategy
    • R&D
    • Commercial
    • Manufacturing
  • Product Portfolio
    • Pipeline
    • Branded Products
    • Generic Products
    • Partnered Products
    • Partnering
  • Therapeutic Area
    • Therapeutic Area
    • Central Nervous System
    • Orphan and Specialty
  • Investors
    • Investors
    • Press Release/News
  • Working at Aucta
    • Careers
    • Employee Value Propostion
  • Contact Us
  • English
    • 简体中文
  • Pipeline
  • Branded Products
  • Generic Products
  • Partnered Products
  • Partnering

17b3df84909c1c5ca6be8d64dfe9801a.jpg


    Vigadrone®(Vigabatrin Powder for Oral                                              Solution)

       Please read the full Prescribing Information




a53e486370be86ad673a18f390bf957c.jpg


 

  Oxcarbazepine Oral Suspension

  Please read the full Prescribing Information




e47a9239ae8d55eec21184380d79b6c9.png


    

 PyquviTM (Deflazacort Oral Suspension)

  Please read the full Prescribing Information




           

 22.png


  ZelvysiaTM (Saproterin Dihydrochloride                       Powder for Oral Solution)

  Please read the full Prescribing Information


  • About Aucta
  • Strategy
  • Product Portfolio
  • Therapeutic Area
  • Investors
  • Contact Us
  • English
Address:71 Suttons Lane, Piscataway, New Jersey 08854 • Phone: +1 (732) 640-0030 • Privacy Policy •  • CA Disclosure